Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Med Case Rep ; 17(1): 3, 2023 Jan 06.
Article in English | MEDLINE | ID: mdl-36604735

ABSTRACT

BACKGROUND: Bradycardia frequently occurs in heart-transplanted patients, mainly as a temporally restricted manifestation early after transplantation and often without symptoms. A high-degree atrioventricular block is mostly symptomatic through cerebral hypoxia induced through cerebral hypoperfusion. Only a few published cases show this specific electroencephalography result in this context. The purpose of this case is to bring attention to atypical manifestations of typical cardiac complications after heart transplantation and the importance of perseverance in the diagnostic. CASE PRESENTATION: A Central European man in his 50s with history of heart transplantation 31 years previously was admitted to the internal medicine ward for short-lived recurrent episodes of generalized weakness with multiple falls but without loss of consciousness. During routine electroencephalography, the patient perceived this recurrent sensation. This episode coincided with a transient third-degree atrioventricular block followed 8-10 seconds later by a generalized slowing of the electroencephalography, reflecting cerebral hypoxia due to cerebral hypoperfusion. Holter monitoring confirmed the diagnosis. A pacemaker was implanted, consequently resolving the episodes. CONCLUSION: This case report illustrates the pathophysiological central hypoxemic origin of episodes of generalized weakness caused by a high-degree atrioventricular block in a patient surviving 29 years after heart transplant. It highlights the benefit of electroencephalography as a diagnostic tool in well-selected patients.


Subject(s)
Atrioventricular Block , Hypoxia, Brain , Pacemaker, Artificial , Vascular Diseases , Male , Humans , Atrioventricular Block/diagnosis , Atrioventricular Block/etiology , Atrioventricular Block/therapy , Pacemaker, Artificial/adverse effects , Electroencephalography/adverse effects , Vascular Diseases/complications , Hypoxia/diagnosis , Hypoxia/etiology , Hypoxia, Brain/etiology , Hypoxia, Brain/complications , Electrocardiography
2.
J Pers Med ; 12(7)2022 Jul 06.
Article in English | MEDLINE | ID: mdl-35887606

ABSTRACT

This study aims to determine which factors within the first week after a first-ever transient ischemic attack (TIA) or minor ischemic stroke (MIS) are associated with stroke survivors' ability to return to either partial or full time paid external work (RTpW). In this single-center prospective cohort study, we recruited 88 patients with first-ever TIA or MIS (NIHSS ≤ 5). Bivariate analyses were conducted between patients that did (RTpW) or did not return to paid work (noRTpW) within 7 days after stroke onset and at 3-months follow-up. Then, we conducted multivariate logistic and negative binomial regression analyses assessing (i) which factors are associated with RTpW at 3 months (ii) the likelihood that patients would RTpW at 3 months and (iii) the number of months necessary to RTpW. Overall, 43.2% of the patients did not RTpW at 3 months. At 3-months follow-up, higher anxiety/depression and fatigue-related disabilities were associated with noRTpW. Multivariate analysis showed that higher NIHSS scores at onset and hyperlipidemia (LDL cholesterol > 2.6 mmol/L or statins at stroke onset) were associated with noRTpW at 3 months. Stroke severity and/or newly diagnosed hypercholesterolemia at stroke onset in TIA or MIS patients were associated with not returning to paid work at 3 months.

3.
Eur J Neurol ; 29(3): 724-731, 2022 03.
Article in English | MEDLINE | ID: mdl-34894018

ABSTRACT

BACKGROUND AND PURPOSE: In Switzerland, the COVID-19 incidence during the first pandemic wave was high. Our aim was to assess the association of the outbreak with acute stroke care in Switzerland in spring 2020. METHODS: This was a retrospective analysis based on the Swiss Stroke Registry, which includes consecutive patients with acute cerebrovascular events admitted to Swiss Stroke Units and Stroke Centers. A linear model was fitted to the weekly admission from 2018 and 2019 and was used to quantify deviations from the expected weekly admissions from 13 March to 26 April 2020 (the "lockdown period"). Characteristics and 3-month outcome of patients admitted during the lockdown period were compared with patients admitted during the same calendar period of 2018 and 2019. RESULTS: In all, 28,310 patients admitted between 1 January 2018 and 26 April 2020 were included. Of these, 4491 (15.9%) were admitted in the periods March 13-April 26 of the years 2018-2020. During the lockdown in 2020, the weekly admissions dropped by up to 22% compared to rates expected from 2018 and 2019. During three consecutive weeks, weekly admissions fell below the 5% quantile (likelihood 0.38%). The proportion of intracerebral hemorrhage amongst all registered admissions increased from 7.1% to 9.3% (p = 0.006), and numerically less severe strokes were observed (median National Institutes of Health Stroke Scale from 3 to 2, p = 0.07). CONCLUSIONS: Admissions and clinical severity of acute cerebrovascular events decreased substantially during the lockdown in Switzerland. Delivery and quality of acute stroke care were maintained.


Subject(s)
COVID-19 , Stroke , Communicable Disease Control , Humans , Pandemics , Retrospective Studies , SARS-CoV-2 , Stroke/epidemiology , Stroke/therapy , Switzerland/epidemiology
4.
Brain ; 144(11): 3392-3404, 2021 12 16.
Article in English | MEDLINE | ID: mdl-34553216

ABSTRACT

In the wake of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, an increasing number of patients with neurological disorders, including Guillain-Barré syndrome (GBS), have been reported following this infection. It remains unclear, however, if these cases are coincidental or not, as most publications were case reports or small regional retrospective cohort studies. The International GBS Outcome Study is an ongoing prospective observational cohort study enrolling patients with GBS within 2 weeks from onset of weakness. Data from patients included in this study, between 30 January 2020 and 30 May 2020, were used to investigate clinical and laboratory signs of a preceding or concurrent SARS-CoV-2 infection and to describe the associated clinical phenotype and disease course. Patients were classified according to the SARS-CoV-2 case definitions of the European Centre for Disease Prevention and Control and laboratory recommendations of the World Health Organization. Forty-nine patients with GBS were included, of whom eight (16%) had a confirmed and three (6%) a probable SARS-CoV-2 infection. Nine of these 11 patients had no serological evidence of other recent preceding infections associated with GBS, whereas two had serological evidence of a recent Campylobacter jejuni infection. Patients with a confirmed or probable SARS-CoV-2 infection frequently had a sensorimotor variant 8/11 (73%) and facial palsy 7/11 (64%). The eight patients who underwent electrophysiological examination all had a demyelinating subtype, which was more prevalent than the other patients included in the same time window [14/30 (47%), P = 0.012] as well as historical region and age-matched control subjects included in the International GBS Outcome Study before the pandemic [23/44 (52%), P = 0.016]. The median time from the onset of infection to neurological symptoms was 16 days (interquartile range 12-22). Patients with SARS-CoV-2 infection shared uniform neurological features, similar to those previously described in other post-viral GBS patients. The frequency (22%) of a preceding SARS-CoV-2 infection in our study population was higher than estimates of the contemporaneous background prevalence of SARS-CoV-2, which may be a result of recruitment bias during the pandemic, but could also indicate that GBS may rarely follow a recent SARS-CoV-2 infection. Consistent with previous studies, we found no increase in patient recruitment during the pandemic for our ongoing International GBS Outcome Study compared to previous years, making a strong relationship of GBS with SARS-CoV-2 unlikely. A case-control study is required to determine if there is a causative link or not.


Subject(s)
COVID-19/complications , Guillain-Barre Syndrome/epidemiology , Adult , Aged , Cohort Studies , Female , Guillain-Barre Syndrome/virology , Humans , Male , Middle Aged , Prospective Studies , SARS-CoV-2
5.
Front Neurol ; 12: 616620, 2021.
Article in English | MEDLINE | ID: mdl-33815247

ABSTRACT

Background and Aims: Timely administration of recombinant tissue plasminogen activator (r-tPA) improves clinical outcomes in acute ischemic stroke patients. This study aims to explore the influence of the systematic presence on site of a neurologist compared with telestroke management on door-to-needle time in acute ischemic stroke outside of working hours (OWH). Methods: This retrospective cohort study included all r-tPA-treated patients in the emergency rooms of two Swiss stroke units, Nyon Hospital [Groupement Hospitalier de l'Ouest Lémanique (GHOL)] and Fribourg Hospital [Hôpital de Fribourg (HFR)], between February 2014 and September 2018. Door-to-needle time was analyzed for patients admitted during working hours (WH' weekdays 08:00-18:00) and OWH (weekdays 18:00-08:00, weekends, and public holidays). The latter was compared between centers; OWH, every patient was evaluated prior to thrombolysis by a neurologist on site in GHOL, while HFR adopted distance neurological supervision with teleradiology, performed by telephone evaluation of relevant clinical information with online real-time access to brain imaging. Results: Data were analyzed for 157 patients in HFR and 101 patients in GHOL. No statistically significant differences in baseline characteristics were found for the 258 r-tPA-treated acute ischemic stroke patients, in terms of age, gender, cardiovascular risk factors (hypertension, diabetes, and atrial fibrillation), and pre-Modified Rankin Scale (pre-mRs) between centers, with the exception of smoking and anticoagulation status. Patients in HFR presented with more severe strokes {median National Institutes of Health Stroke Scale (NIHSS) [6 (SD 6.88) (GHOL), 8 (SD 6.98) (HFR), p = 0.005]}. No significant differences in baseline characteristics were found as per admission time independently of the center. Door-to-needle time was significantly longer in the HFR cohort when compared with GHOL, irrespective of admission time. Both centers demonstrated significantly longer median door-to-needle time OWH. However, analysis of the door-to-needle time differences between WH and OWH showed no significant interaction using robust ANCOVA WRS2 analysis (p = 0.952) and a Bayesian model (BF01 = 3.97). Conclusions: On-site systematic evaluation by a neurologist did not appear to influence door-to-needle time OWH, suggesting distance supervision may be time-efficient in thrombolysis. This supports existing prospective studies in hyperacute telestroke management. The relevance lies in optimizing resource use considering the increasing demand for emergency neurological management.

6.
Case Rep Neurol Med ; 2017: 9289218, 2017.
Article in English | MEDLINE | ID: mdl-29109882

ABSTRACT

A 54-year-old patient presented with mild right-sided weakness of hand and face with a National Institutes of Health Stroke Scale (NIHSS) of 2 and occlusion of the left middle cerebral artery (MCA) in the M1 segment with a large perfusion deficit on computed tomography (CT). Due to mild neurological deficits no IVT was performed. Nine hours after symptom onset the patient gradually deteriorated with a NIHSS fluctuating between 9 and 15. MRI showed a persistent occlusion of the MCA with a large diffusion-perfusion mismatch. Immediate endovascular thrombectomy was performed 14 hours after symptom onset with complete recanalization and complete clinical recovery. Although mechanical thrombectomy is generally considered an effective alternative strategy up to 8 hours after stroke onset, selected patients with a large diffusion/perfusion mismatch and small infarct cores may benefit from an expanded therapeutic window.

7.
BMJ Case Rep ; 20172017 Aug 07.
Article in English | MEDLINE | ID: mdl-28784886

ABSTRACT

A 67-year-old patient, only known for bilateral presbycusis, presented with subacute onset of delirium. Clinical examination showed multifocal neurological deficits, all together suggesting subcortical frontal dysfunction together with cerebellar and corpus callosum involvement.Cerebral MRI demonstrated supratentorial and infratentorial subcortical and periventricular T2-hyperintense lesions with cerebellar gadolinium enhancement and multiple central lesions of the corpus callosum (snowball lesions). The diagnosis of Susac syndrome was made and the patient treated with intravenous methylprednisolone, followed by a prednisone maintenance dose over 8 weeks. After a clinical improvement, a relapse was noticed during corticosteroid tapering. The patient was again treated with intravenous methylprednisolone followed by a prednisone maintenance therapy with simultaneous introduction of mycophenolate mofetil acid and one cycle of intravenous rituximab. The patient recovered rapidly. At 11-month follow-up, only mild executive dysfunction and persistent right postural tremor was noted, MRI showed partial regression of subcortical and juxtacortical lesions.


Subject(s)
Delirium/etiology , Late Onset Disorders/psychology , Susac Syndrome/psychology , Aged , Humans , Male , Recurrence
8.
J Neurosurg Spine ; 26(6): 684-687, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28291413

ABSTRACT

Harlequin syndrome is a rare autonomic disorder referring to the sudden development of flushing and sweating limited to one side of the face. Like Horner syndrome, associating miosis, ptosis, and anhidrosis, Harlequin syndrome is caused by disruption of the cervical sympathetic pathways. Authors of this report describe the case of a 55-year-old female who presented with both Harlequin sign and Horner syndrome immediately after anterior cervical discectomy (C6-7) with cage fusion and anterior spondylodesis. They discuss the pathophysiology underlying this striking phenomenon and the benign course of this condition. Familiarity with this unusual complication should be of particular interest for every specialist involved in cervical and thoracic surgery.


Subject(s)
Autonomic Nervous System Diseases/etiology , Cervical Vertebrae/surgery , Diskectomy/adverse effects , Flushing/etiology , Horner Syndrome/etiology , Hypohidrosis/etiology , Postoperative Complications , Autonomic Nervous System Diseases/physiopathology , Female , Flushing/physiopathology , Horner Syndrome/physiopathology , Humans , Hypohidrosis/physiopathology , Intervertebral Disc Displacement/physiopathology , Intervertebral Disc Displacement/surgery , Middle Aged , Postoperative Complications/physiopathology , Radiculopathy/physiopathology , Radiculopathy/surgery , Spinal Fusion/adverse effects
10.
Rev Med Suisse ; 9(410): 2345-9, 2013 Dec 11.
Article in French | MEDLINE | ID: mdl-24416983

ABSTRACT

In Switzerland, because of the ageing of the population, the number of dementia's cases grows up. This represents a notable social and economic impact. The early detection is the key for a best patient's care. The general practitioner can use, in addition to his clinical approach, a certain number of screening tools in order to detect and diagnose dementia with an acceptable specificity and sensitivity (around 80%). Amongst these tools, we describe a four question questionnaire to the informants, the Mini Mental State Examination, the clock drawing test and the Mementool. A supplementary screening task, the 5 words test can orientate the diagnosis towards an Alzheimer disease or another form of dementia.


Subject(s)
Dementia/diagnosis , Community Medicine , Decision Trees , Family Practice , Humans , Psychiatric Status Rating Scales , Surveys and Questionnaires
11.
Muscle Nerve ; 46(2): 264-6, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22806376

ABSTRACT

INTRODUCTION: Velocity recovery cycles (VRCs) of human muscle action potentials have been proposed as a new technique for studying muscle membrane function. This study was undertaken to determine the temperature dependency of VRC parameters. METHODS: VRCs with 1 conditioning stimulus were recorded repeatedly from brachioradialis muscle during cooling, and intramuscular temperature was recorded. VRCs in 6 normal volunteers were measured at 1°C intervals from 34°C to 28°C. The effects of temperature on relative refractory period and early and late supernormality were quantified. RESULTS: Muscle VRC curves shift progressively upward and to the right with cooler temperatures. The most sensitive parameter to temperature changes was relative refractory period, whereas early supernormality was rather insensitive. Late supernormality was unaffected by temperature changes. CONCLUSIONS: Knowledge of temperature-induced changes of muscle VRC parameters is essential for future studies. Thus, the results of this study provide a firm basis for clinical studies with this technique.


Subject(s)
Muscle Contraction/physiology , Muscle, Skeletal/physiology , Refractory Period, Electrophysiological/physiology , Temperature , Action Potentials/physiology , Adult , Electric Stimulation , Female , Humans , Male
12.
Clin Neurophysiol ; 122(11): 2294-9, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21555240

ABSTRACT

OBJECTIVE: Velocity recovery cycles (VRCs) of human muscle action potentials have been proposed as a new technique for assessing muscle membrane function in myopathies. This study was undertaken to determine the variability and repeatability of VRC measures such as supernormality, to help guide future clinical use of the method. METHODS: To assess repeatability, VRCs with one and two conditioning stimuli were recorded from brachioradialis muscle by direct muscle stimulation in 20 normal volunteers, and the measurements repeated 1 week later. To further assess variability and dependence on electrode separation, age and sex, recordings from an additional 20 normal volunteers were added. RESULTS: There was a high intraclass correlation between repeated recordings of early supernormality, indicating excellent reliability of this VRC measure. However, relative refractory period had a smaller coefficient of repeatability in relation to the changes previously described during ischemia. We found no evidence that any of the excitability measures depended on electrode separation, conduction time or apparent velocity. There were also no significant differences between the recordings from men and women, or between the recordings from older (mean 44.9 y) and younger (26.5 y) subjects. CONCLUSIONS: VRC measures are sufficiently consistent to be suitable for comparing muscle membrane function both within subjects and between groups. Early supernormality measurements benefit most from within subject comparisons. SIGNIFICANCE: These normative data sets provide a firm basis for planning clinical studies.


Subject(s)
Action Potentials/physiology , Muscle Contraction/physiology , Muscle, Skeletal/physiology , Recovery of Function/physiology , Refractory Period, Electrophysiological/physiology , Adult , Aged , Aging/physiology , Conditioning, Psychological/physiology , Electric Stimulation/instrumentation , Electric Stimulation/methods , Female , Humans , Male , Middle Aged , Muscle, Skeletal/innervation , Reaction Time/physiology , Sarcolemma/physiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...